Displaying drugs 2051 - 2075 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Avacopan | 581.656 C33H35F4N3O2 |  | An orally bioavailable complement 5a receptor (C5aR) antagonist for the treatment of severe anti-neutrophil cytoplasmic (auto)antibody (ANCA)-associated vasculitis. | Complement Inactivating Agents / Selective Immunosuppressants |
| Atorvastatin | 558.6398 C33H35FN2O5 |  | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. | Anticholesteremic Agents / Heptanoic Acids / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypolipidemic Agents Indicated for Hyperlipidemia |
| Ergotamine | 581.6615 C33H35N5O5 |  | An alpha-1 selective adrenergic agonist vasoconstrictor used to treat migraines with or without aura and cluster headaches. | Ergot Alkaloids and Derivatives |
| Dihydroergotamine | 583.6774 C33H37N5O5 |  | An ergot alkaloid used in the acute treatment of migraine headache and cluster headache. | Ergot Alkaloids and Derivatives |
| Gadofosveset trisodium | 1003.85 C33H38GdN3Na5O14P |  | An intravenous contrast agent used during magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with peripheral vascular disease. | Paramagnetic Contrast Media |
| Irinotecan | 586.678 C33H38N4O6 |  | A topoisomerase inhibitor used to treat metastatic carcinoma of the colon or rectum and pancreatic adenocarcinoma. | Topoisomerase 1 (TOP1) inhibitors |
| Glycerol phenylbutyrate | 530.6512 C33H38O6 |  | A nitrogen-binding agent used to manage patients with urea cycle disorders who cannot be sufficiently managed amino acid supplementation and/or dietary restrictions. | Various Alimentary Tract and Metabolism Products |
| Reserpine | 608.6787 C33H40N2O9 |  | For the treatment of hypertension | Secologanin Tryptamine Alkaloids |
| Omaveloxolone | 554.723 C33H44F2N2O3 |  | A semisynthetic triterpenoid used to treat Friedreich’s ataxia in adults and adolescents 16 years and older. | Anti-Inflammatory Agents / Antioxidants / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (weak) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / OAT1/SLC22A6 inhibitors / Oxidation-Reduction Agent / Terpenes / Triterpenes |
| Natamycin | 665.733 C33H47NO13 |  | A macrolide antifungal used to treat fungal infections of the eye. | Anti-Bacterial Agents / Antiinfectives and Antiseptics for Local Oral Treatment |
| alpha-Tocopherol succinate | 530.79 C33H54O5 |  | A form of vitamin E used to treat and prevent vitamin deficiencies. | Antioxidants / Tocopherols / Vitamins |
| Tocofersolan | C33H54O5(C2H4O)n |  | A derivative of alpha tocopherol used to treat vitamin E deficiencies. | Drug Carriers |
| Fusafungine | 639.8204 C33H57N3O9 |  | Fusafungine is an antibiotic from Fusarium lateririum, and is used for the treatment of respiratory infections. | Anti-Bacterial Agents |
| Nonoxynol-9 | 616.8235 C33H60O10 |  | A vaginal spermicide used for the non-hormonal contraception in conjunction with other modes of contraception. | Polyethylene Glycols / Spermatocidal Agents / Surface-Active Agents |
| Lumefantrine co-artemether | 6116.74 C346H378Cl33N11O16 |  | Lumefantrine Co-Artemether (Riamet) has been investigated for the treatment of Malaria, Malaria, Falciparum, Malaria in Pregnancy, Uncomplicated Malaria, and Uncomplicated Knowlesi Malaria. Lumefantrine Co-Artemether is a tablet formulation of artemether... | Not Annotated |
| Trypan blue free acid | 872.87 C34H28N6O14S4 |  | A dye used as a visualizing aid to stain the epiretinal membranes during ophthalmic surgical vitrectomy procedures, thereby facilitating removal of the tissue. | Azo Compounds / Coloring Agents / Diagnostic Dye / Naphthalenesulfonates |
| Valrubicin | 723.651 C34H36F3NO13 |  | An anthracycline used intravesically in the treatment of BCG-resistant bladder carcinoma. | Anthracyclines and Related Substances |
| Dabigatran etexilate | 627.7332 C34H41N7O5 |  | An anticoagulant used for the prevention of venous thromboembolic events or stroke in patients with recent elective hip or knee replacement surgery and atrial fibrillation. | Antithrombins / Benzimidazoles / Pyridines |
| Tazemetostat | 572.75 C34H44N4O4 |  | A methyltransferase inhibitor indicated to treat patients 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. | Methyltransferase Inhibitor |
| Dalfopristin | 690.85 C34H50N4O9S |  | An antibiotic used with quinupristin to treat severe or life-threatening infections of vancomycin-resistant Enterococcus faecium (VREF), and skin infections caused by methicillin susceptible staphylococcus aureus or streptococcus pyogenes. | Anti-Bacterial Agents / Streptogramin Antibacterial |
| Naloxegol | 651.794 C34H53NO11 |  | A peripherally-selective opioid antagonist used to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. | Peripheral Opioid Receptor Antagonists |
| Vecuronium | 557.8274 C34H57N2O4 |  | A nondepolarizing neuromuscular blocking agent used to relax muscles or as an adjunct in general anesthesia during surgical procedures. | Androstanols / Neuromuscular-Blocking Agents (Nondepolarizing) / Nicotinic Antagonists |
| DL-dimyristoylphosphatidylglycerol | 666.874 C34H67O10P |  | DL-dimyristoylphosphatidylglycerol is not an considered an active pharmacological ingredient in pharmaceutical preparations and so has no official indications. | Glycerophosphates / Glycerophospholipids / Lipids / Membrane Lipids / Phosphatidic Acids / Phospholipids |
| Midostaurin | 570.649 C35H30N4O4 |  | An antineoplastic agent used to treat high-risk acute myeloid leukemia (AML) with specific mutations, aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL). | Protein Kinase Inhibitors |
| Isavuconazonium | 717.77 C35H35F2N8O5S |  | A triazole antifungal used for the treatment of invasive aspergillosis and mucormycosis. | Antifungal Agents / Azole Antifungals |
Displaying drugs 2051 - 2075 of 2785 in total